Early disease progression in patients (pts) with newly diagnosed localized nasal extranodal NK/T-cell lymphoma, nasal type (ENKL) treated with radiotherapy with dexamethasone, etoposide, ifosfamide, and carboplatin (RT-DeVIC)
Early disease progression in patients (pts) with newly diagnosed localized nasal extranodal NK/T-cell lymphoma, nasal type (ENKL) treated with radiotherapy with dexamethasone, etoposide, ifosfamide, and carboplatin (RT-DeVIC)
复制标题
新诊断的鼻型局部结外 NK/T 细胞淋巴瘤 (ENKL) 接受地塞米松、依托泊苷、异环磷酰胺和卡铂放疗 (RT-DeVIC) 患者的早期疾病进展
DOI：
--
复制
发表时间：
2017
期刊：
影响因子：
--
通讯作者：
NKEA project.
中科院分区：
文献类型：
--
作者：
Yamaguchi M;Suzuki R;Oguchi M;Asano N;Miyazaki K;Terui Y;Kubota N;Maeda T;Kobayashi Y;Amaki J;Soejima T;Saito B;Shimoda E;Fukuhara N;Tsukamoto N;Shimada K;Choi I;Utsumi T;Ejima Y;Katayama N;NKEA project.
